Capital Increase / Dilution2026-04-22
CB Issuance
에스바
에스바이오메딕스
304360
Signal Score
60B — Moderate Signal
Score60 / 100
Historical Avg Return (5d)
+1.76%
Data Coverage
100%n=1414
Risk-adjusted indicator based on 1414 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Issuance Amount: 22,200,000,000 KRW
- • Issuance Date: 2026-04-22
3 more figures — unlock with API access
AI Analysis Summary
Developer & Pro plans
Risk Factors
Developer & Pro plans
Access Full Korean Market Signal Analytics
✔ AI-parsed DART filing classification & scoring
✔ Real-time event impact indicators
✔ Historical pattern data via REST API
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.
AI-processed analysis. Based on: 증권발행결과(자율공시) (제7회차 CB). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.